Target intelligence / Profile preview

Disintegrin and metalloproteinase domain-containing protein 28 (ADAM28)

Target
ADAM28
Molecular classification
Enzyme, Metalloendopeptidase, Disintegrin and metalloproteinase family, Cell surface protein
01

Overview

Disintegrin and metalloproteinase domain-containing protein 28 (ADAM28) is a membrane-anchored and secreted metalloendopeptidase belonging to the ADAM family. It is encoded by the ADAM28 gene on chromosome 8p21.2. ADAM28 is involved in processes such as cell–cell and cell–matrix interactions, ectodomain shedding of surface proteins (notably FAS ligand and CD40 ligand), and plays roles in immune cell migration and possibly sperm maturation. It has both transmembrane and secreted isoforms. Its expression and activity have been associated with disease states including certain cancers and neurological conditions. As of now, ADAM28 is a putative biomarker and an experimental drug target due to its involvement in cell adhesion, proteolysis, and tissue remodeling[1][3][4][5][7][9].

Other names
ADAM28ADAM 28ADAM23 (sometimes listed, but note official gene is ADAM28)eMDC IIMDC-LMDCLMetalloproteinase-like, disintegrin-like, and cysteine-rich protein LEpididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II
02

Mechanism of action

null (no clinically validated drugs specifically targeting ADAM28; experimental inhibition or gene silencing would be expected to block ectodomain shedding and cell interaction pathways)

03

Biological functions

Cell–cell interactionCell–matrix interactionEctodomain shedding (cleaving extracellular domain portions of proteins)Lymphocyte migration/emigrationSperm maturationImmunoglobulin receptor binding
04

Disease associations

Cancer (including a described association with colon cancer and potential for other cancers)Neurological disorders (e.g. epilepsy, familial temporal lobe)Hyperostosis Cranialis InternaPotential immune-related and reproductive roles
05

Safety considerations

Potential off-target effects due to the protein's role in immune cell migration and sperm maturationDisruption might impact normal immune or reproductive function
06

Biomarkers

Serum ADAM28 levels have been reported as correlated with the clinical stage of colon cancer

Beyond the preview

Go deeper on Disintegrin and metalloproteinase domain-containing protein 28 (ADAM28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disintegrin and metalloproteinase domain-containing protein 28 (ADAM28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call